Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in medical and aesthetic dermatology. The Company is focused on underserved market segments with no FDA-approved medications or where treatment gaps exist.
Headquartered in Malvern, Pennsylvania, Aclaris was founded in 2012. The Company is led by a team with approximately 250 years of combined experience in developing and commercializing dermatologic treatments. The team’s insight into the needs of dermatologists, their patients and the complex regulatory and drug development landscape enables Aclaris to identify early-stage drug candidates with the potential to meet those needs. Aclaris is advancing a drug portfolio of innovative therapies to treat skin and hair conditions that adversely impact how patients look, feel and live.